E.E. Geduld’s Apyx Medical APYX Stock Holding History

E.E. Geduld’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-25,000	Closed	-$70K	–	212
2015 Q2	$70K	Buy	+25,000	New	+$68.8K	0.04%	225

Other funds holding APYX

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Apis Capital Advisors New York $1.03B AUM 383.18% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

E.E. Geduld's APYX Position: Q3 2015 in Review

E.E. Geduld sold out of Apyx Medical (APYX) in Q3 2015, closing a stake of 25,000 shares — an estimated $70K sold.

E.E. Geduld first reported a position in APYX in Q2 2015 and held it in 1 quarter. The position peaked at $70K in Q2 2015. 31 funds tracked by Wall St. Rank hold APYX as of Q3 2015.

E.E. Geduld reported no remaining Apyx Medical position as of Q3 2015 after selling out during the quarter.
E.E. Geduld sold 25,000 Apyx Medical shares in Q3 2015, an estimated $70K.
E.E. Geduld first reported a position in Apyx Medical in Q2 2015 and held it in 1 quarter.
E.E. Geduld's Apyx Medical position peaked at $70K in Q2 2015.
31 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2015.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.